Skeletal Stem Cell Isolation Using BMPR1A Marker

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The lack of a cell surface marker for skeletal stem cells (SSCs) and suture stem cells (SuSCs) hinders their isolation and maintenance ex vivo, limiting advances in skeletal regeneration.

Innovation Solution

Identification and use of BMPR1A as a cell surface marker for SSCs and SuSCs, along with specific methods for isolation and enrichment, including fluorescence-activated cell sorting, and maintenance in vitro using a low-attachment surface culture medium.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional methods are used for cell isolation, then general cell populations can be obtained, but specific skeletal stem cells cannot be effectively isolated due to lack of cell surface markers

Engineering Contradiction:
Improvecell identification accuracyVSAvoidisolation method complexity
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent utilizes fluorescent labeling of the BMPR1A cell surface marker to enable visual identification and sorting of skeletal stem cells. By conjugating antibodies against BMPR1A with fluorescent dyes, the cells of interest can be detected and isolated with high precision through flow cytometry, resolving the contradiction between identification accuracy and method complexity.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The patent employs antibodies as intermediary molecules that specifically bind to the BMPR1A cell surface marker on skeletal stem cells. These antibodies serve as mediators between the target cells and the isolation technology (flow cytometry or magnetic sorting), enabling specific enrichment of SSCs from mixed cell populations without requiring direct manipulation of the cells themselves.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If standard culture conditions are used, then cell growth can occur, but stemness characteristics are lost during ex vivo maintenance

Engineering Contradiction:
Improvecell proliferation rateVSAvoidstemness maintenance
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent modifies culture conditions by supplementing the medium with specific growth factors (BMP-2, BMP-4, FGF-2, IGF-1) and cytokines at optimized concentrations. These parameter changes in the culture environment maintain stemness characteristics while allowing cell proliferation, resolving the contradiction between productivity and composition stability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent establishes a continuous culture system where skeletal stem cells are maintained in an optimized medium composition throughout the culture period. This continuous provision of stemness-maintaining factors ensures that the cells retain their multipotent characteristics while proliferating, preventing the loss of stemness that occurs in standard intermittent culture conditions.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables effective isolation and maintenance of SSCs and SuSCs, preserving their osteogenic ability and self-renewal properties, facilitating bone regeneration and tissue engineering applications.

Implementation Method 1

The BMPR1A+ cell or cells can be identified, isolated, or enriched by fluorescence activated cell sorting

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20240124845A1Skeletal stem cell isolation and uses thereof
Publication Date: 2024.04.18 UNIVERSITY OF ROCHESTER
  • US20240124845A1 patent drawing
  • US20240124845A1 patent drawing
  • US20240124845A1 patent drawing

AI summary

This application relates to stem cell biology and regenerative medicine. Disclosed herein methods for isolation of skeletal stem cells, related methods, related compositions, related products, and related uses.